Cover Image

CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer

Abstract Tumor microenvironment and chemokines play a significant role in cancer chemoresistance. This study was designed to reveal the important role of CXCL2 in platinum resistance in epithelial ovarian cancer (EOC). Differently expressed (DE) genes were screen out based on analysis of GSE114206 d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sipei Nie (Author), Yicong Wan (Author), Hui Wang (Author), Jinhui Liu (Author), Jing Yang (Author), Rui Sun (Author), Huangyang Meng (Author), Xiaolin Ma (Author), Yi Jiang (Author), Wenjun Cheng (Author)
Format:	Book
Published:	BMC, 2021-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Indigofera suffruticosa aerial parts extract induce G2/M arrest and ATR/CHK1 pathway in Jurkat cells
by: Hong-Loan Tran, et al.
Published: (2024)

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer
by: Cui Q, et al.
Published: (2021)

NSC746364, a G-Quadruplex-Stabilizing Agent, Suppresses Cell Growth of A549 Human Lung Cancer Cells Through Activation of the ATR/Chk1-Dependent Pathway
by: Yun-Lung Chung, et al.
Published: (2014)

Functions and inhibitors of CHK1 in cancer therapy
by: Kailong Jiang, et al.
Published: (2024)

Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon
by: Reem Abdallah, et al.
Published: (2023)

Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer
by: Zhongmian Pan, et al.
Published: (2023)

Evaluation of Pegylated Liposomal Doxorubicin in the Treatment Of Both Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer
by: Hao Lin, et al.
Published: (2004)

A nomogram to predict platinum-sensitivity and survival outcome in women with advanced epithelial ovarian cancer
by: Tsung-Hsin Yeh, et al.
Published: (2024)

High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer
by: Jinfeng Wang, et al.
Published: (2024)

Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
by: Wenwen Chien, et al.
Published: (2023)

External validation of Standardized KELIM and platinum-resistant recurrence scores in patients with advanced epithelial ovarian cancer
by: Nina Oufkir, et al.
Published: (2024)

Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer
by: Sipei Nie, et al.
Published: (2023)

CXCL14 facilitates the growth and metastasis of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway
by: Li-Na Gao, et al.
Published: (2021)

Off-label use of paclitaxel and pembrolizumab in a case of platinum refractory epithelial ovarian cancer and extensive thromboembolism
by: Clarissa Lam, et al.
Published: (2022)

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
by: Yan Rong, et al.
Published: (2021)

Efficacy And Safety Of Apatinib Treatment In Platinum-Resistant Recurrent Epithelial Ovarian Cancer: A Real World Study
by: Zhang J, et al.
Published: (2019)

Differential Effect of Schisandrin B Stereoisomers on ATR-Mediated DNA Damage Checkpoint Signaling
by: Naoto Tatewaki, et al.
Published: (2013)

CT radiomics prediction of CXCL9 expression and survival in ovarian cancer
by: Rui Gu, et al.
Published: (2023)

ADC: a deadly killer of platinum resistant ovarian cancer
by: Xu Cheng, et al.
Published: (2024)

Expression and Secretion of CXCL-8 and CXCL-10 From Mycobacterium Bovis BCG-Infected Human Epithelial Cells: Role of IL-4
by: Patricia Méndez-Samperio, et al.
Published: (2006)

PharmaChk: Poor quality medicines screening tool for resource-limited areas
by: A. Fernandes, et al.
Published: (2015)

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
by: Chung Jae, et al.
Published: (2009)

Sponge-derived alkaloid AP-7 as a sensitizer to cisplatin in the treatment of multidrug-resistant NSCLC via Chk1-dependent mechanisms
by: Li Guan, et al.
Published: (2024)

Expression and Secretion of CXCL-8 and CXCL-10 From <emph>Mycobacterium Bovis</emph> BCG-Infected Human Epithelial Cells: Role of IL-4
Published: (2006)

CHK2 Promotes Metabolic Stress-Induced Autophagy through ULK1 Phosphorylation
by: Ran Guo, et al.
Published: (2022)

Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: Its possible clinical significance
by: Yin-Ting Chuang, et al.
Published: (2012)

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
by: Dhammapoj Jeerakornpassawat, et al.
Published: (2020)

Prospects for the Use of ATR Inhibitors to Treat Cancer
by: Scott H. Kaufmann, et al.
Published: (2010)

Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways
by: Minjie Zhang, et al.
Published: (2021)

Associations of CXCL1 gene 5'UTR variations with ovarian cancer
by: Man Guo, et al.
Published: (2020)

The effect of transplantation of cultured autologous melanocytes on CXCL9, CXCL10 and CXCL11 expressions in vitiligo
by: Chen Xu, et al.
Published: (2023)

CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway
by: Meng-Yao Sun, et al.
Published: (2019)

The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
by: K. E. Borisov
Published: (2014)

A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
by: Shoji Nagao, et al.
Published: (2020)

A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet
by: Hope Cottrill MD, et al.
Published: (2018)

Involvement of CXCL12/CXCR4 in the motility of human first-trimester endometrial epithelial cells through an autocrine mechanism by activating PI3K/AKT signaling
by: Jiayi Zheng, et al.
Published: (2020)

ATR versus periodización tradicional en tenistas amateur adolescentes
by: Pablo Prieto González, et al.
Published: (2021)

Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling
by: Ahmed Dhahir Latif, et al.
Published: (2020)

Modern strategies of platinum resistance overcoming in patients with the serous ovarian cancer
by: Andriy Rybin
Published: (2018)

Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives
by: McClung EC, et al.
Published: (2016)